11/19/2024
3:48 PM | Akari Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/18/2024
7:02 PM | Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
3:27 PM | Akari Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
7:00 AM | Akari Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2024
5:00 PM | Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
7:51 AM | Akari Therapeutics (Subject)
| Form 425 | |
10/14/2024
11:15 PM | Akari Therapeutics (Filer)
| Form EFFECT | |
|
10/11/2024
3:52 PM | Akari Therapeutics (Filer)
| Form 424B3 | |
10/09/2024
3:27 PM | Akari Therapeutics (Filer)
| Form S-4/A | |
10/04/2024
3:30 PM | Akari Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2024
5:34 PM | Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
5:43 AM | Akari Therapeutics (Filer)
| Form S-4/A | |
09/18/2024
3:34 PM | Akari Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/18/2024
3:36 PM | Akari Therapeutics (Issuer)
Bazemore Robert B (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/18/2024
3:40 PM | Akari Therapeutics (Issuer)
Bazemore Robert B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/15/2024
11:15 PM | Akari Therapeutics (Filer)
| Form EFFECT | |
09/13/2024
4:30 PM | Akari Therapeutics (Filer)
| Form S-4
Registration statement under Securities Act of 1933 | |
09/06/2024
4:23 PM | Akari Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
09/06/2024
4:07 PM | Akari Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/23/2024
3:30 PM | Akari Therapeutics (Filer)
| Form 8-K/A | |
08/19/2024
3:30 PM | Akari Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/19/2024
3:15 PM | Akari Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/15/2024
3:15 PM | Akari Therapeutics (Filer)
| Form NT 10-Q | |
07/02/2024
3:30 PM | Akari Therapeutics (Issuer)
Akari Therapeutics (Issuer)
Prudo-Chlebosz Raymond (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
3:30 PM | Akari Therapeutics (Issuer)
WILLIAMS DONALD A (Reporting)
WILLIAMS DONALD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
3:30 PM | Akari Therapeutics (Issuer)
Hashad Mohamed Wa'el Ahmed (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
3:30 PM | Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
Patel Samir Rashmikant (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
3:30 PM | Akari Therapeutics (Issuer)
Akari Therapeutics (Issuer)
Grissinger Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
6:30 AM | Akari Therapeutics (Subject)
RPC Pharma Ltd (Filed by)
| Form SC 13D/A | |
06/07/2024
5:00 PM | Akari Therapeutics (Subject)
Patel Samir Rashmikant (Filed by)
| Form SC 13D | |
06/04/2024
3:45 PM | Akari Therapeutics (Issuer)
Prudo-Chlebosz Raymond (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
3:45 PM | Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
3:30 PM | Akari Therapeutics (Subject)
| Form 425 | |
06/04/2024
7:02 AM | Akari Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/16/2024
7:05 AM | Akari Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
3:47 PM | Akari Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/01/2024
4:27 PM | Akari Therapeutics (Subject)
| Form 425 | |
05/01/2024
4:04 PM | Akari Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2024
8:45 PM | Akari Therapeutics (Issuer)
Jacques Rachelle Suzanne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2024
5:30 AM | Akari Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2024
5:30 AM | Akari Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Trump said you could learn something from this man (Ad) Early Warning: A Deep Crack Is Forming In The US Economy
Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement.  Here’s everything you need to know. |
03/29/2024
3:15 PM | Akari Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/11/2024
4:25 PM | Akari Therapeutics (Subject)
| Form 425 | |
03/11/2024
4:24 PM | Akari Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2024
7:28 AM | Akari Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2024
7:34 AM | Akari Therapeutics (Subject)
| Form 425 | |
01/09/2024
4:25 PM | Akari Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
01/04/2024
11:34 AM | Akari Therapeutics (Subject)
RPC Pharma Ltd (Filed by)
| Form SC 13D/A | |
01/02/2024
7:00 PM | Akari Therapeutics (Issuer)
DICICCO WENDY F (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
7:06 PM | Akari Therapeutics (Issuer)
Jacques Rachelle Suzanne (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
6:56 PM | Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
6:49 PM | Akari Therapeutics (Issuer)
Hashad Mohamed Wa'el Ahmed (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
5:58 PM | Akari Therapeutics (Issuer)
Prudo-Chlebosz Raymond (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
5:35 PM | Akari Therapeutics (Issuer)
WILLIAMS DONALD A (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
5:41 PM | Akari Therapeutics (Issuer)
Grissinger Michael (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/01/2023
7:00 AM | Akari Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
